Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 159INDUSTRY 20NIH 12OTHER_GOV 3FED 2INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 4Neoplasms 2Myasthenia Gravis 2Warts 1Vaginosis, Bacterial 1Uterine Cervical Neoplasms 1Syphilis 1Sexually Transmitted Diseases 1Retroperitoneal liposarcoma 1Pilonidal Sinus 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Liposarcoma 1Leiomyosarcoma 1Herpes Genitalis 1HIV Infections 1Gonorrhea 1Esophageal Neoplasms 1Endometrial Neoplasms 1Chondrosarcoma 1Chlamydia Infections 1Barrett Esophagus 1Anemia 1

Interventions

olaparib 1PM 01183 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × INDIV × Endometrial Neoplasms × Clear all
NCT02684318 2017-06-22

Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

Poveda, Andrés, M.D.

Phase 1/2 Unknown
100 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡